Consequences of MEGF10 deficiency on myoblast function and Notch1 interactions

Area of Science:

• Muscle biology
• Cellular signaling
• Genetics

Background:

• Mutations in MEGF10 are linked to early onset myopathy, areflexia, respiratory distress, and dysphagia (EMARDD).
• The precise pathogenic mechanisms underlying EMARDD remain largely unknown.
• MEGF10's role in muscle development and disease pathogenesis requires further elucidation.

Purpose of the Study:

• To investigate the functional consequences of MEGF10 mutations on myoblast behavior.
• To explore the interaction between MEGF10 and the Notch signaling pathway in myogenesis.
• To identify potential molecular mechanisms contributing to EMARDD.

Main Methods:

• Short hairpin RNA (shRNA)-mediated knockdown of Megf10 in C2C12 cells.
• Overexpression of a pathogenic human MEGF10 mutation (p.C774R).
• Analysis of myoblasts from Megf10-/- and Megf10-/-/mdx double knockout mice.
• Reciprocal co-immunoprecipitation assays to assess protein interactions.

Main Results:

• Knockdown or pathogenic mutation of MEGF10 impaired C2C12 myoblast proliferation and migration.
• Megf10-/- myoblasts exhibited reduced proliferation and migration compared to wild-type.
• Double knockout mice displayed unique histological abnormalities, suggesting synergistic effects.
• MEGF10 directly interacts with Notch1 via their intracellular domains, an interaction disrupted by the p.C774R mutation.

Conclusions:

• MEGF10 plays a critical role in regulating myoblast proliferation and migration.
• MEGF10's function in myogenesis is partially mediated through interactions with the Notch signaling pathway.
• Disruption of MEGF10-Notch interactions may underlie the pathogenesis of EMARDD.